Chilli pepper supplements barely move your cholesterol

Chilli pepper extracts and capsaicin-based supplements are sold with broad metabolic promises, and whether Capsicum annuum genuinely helps control blood fats has remained unclear. Dyslipidaemia, an unhealthy pattern of cholesterol and triglycerides, is a central feature of metabolic syndrome and a driver of cardiovascular risk, so a cheap food-derived supplement with a real lipid effect would matter to a lot of people. Individual trials on capsicum and lipids have been small and scattered, which is why pooling them is the sensible way to ask whether a consistent effect exists at all.

The author searched PubMed, Scopus, ISI Web of Science and the Cochrane Library for randomised controlled trials published up to March 2021 that compared Capsicum annuum supplementation against a control and measured lipid markers in adults with metabolic syndrome and related disorders. Four eligible trials were identified. Their results were combined as weighted mean differences, producing one pooled estimate for each lipid outcome: total cholesterol, triglycerides, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol.

Pooled across the four trials, capsicum supplementation significantly reduced total cholesterol, by a weighted mean difference of 4.98 mg/dL compared with control. That was the only lipid marker to move. Triglycerides did not change, HDL cholesterol did not change, and LDL cholesterol did not change either. The headline benefit is therefore real but narrow: a small dip in total cholesterol, with the individual components of the lipid profile that clinicians usually target left essentially untouched.

This finding sits between promising and negligible. It suggests capsicum has some biological activity on blood lipids, which supports continued research interest, but the effect on total cholesterol is modest, and the absence of any change in LDL, HDL or triglycerides limits its practical meaning. The author is explicit that only four trials qualified, and that trials with adequate sample sizes, specifically in people with dyslipidaemia, are needed before a firm link between capsicum and lipid control can be drawn.

If you enjoy chilli, nothing here argues against it, but if you were considering capsicum capsules to fix your cholesterol, this pooled evidence offers little support. A 4.98 mg/dL drop in total cholesterol is small, and the markers that carry most weight in cardiovascular risk did not shift at all. It is a reason to treat metabolic claims on pepper-extract supplements with scepticism until larger trials in people with raised blood fats report, and a reminder that a statistically detectable effect is not the same as a meaningful one.